Description: 22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. It develops smoking cessation products for smokers who are unable or unwilling to quit smoking; and modified risk tobacco products that reduce exposure to certain tobacco smoke toxins compared to conventional cigarettes. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy; RED SUN and MAGIC regular and menthol cigarettes; and SPECTRUM government research cigarettes. It is also developing modified risk cigarettes, such as BRAND A, which has approximately 95% less nicotine than tobacco in cigarettes; and BRAND B cigarettes' with smoke that contains the lowest amount of tar per milligram of nicotine. 22nd Century Group, Inc. was founded in 1998 and is based in Clarence, New York.
Home Page: www.xxiicentury.com
XXII Technical Analysis
500 Seneca Street
Buffalo,
NY
14204
United States
Phone:
716 270 1523
Officers
Name | Title |
---|---|
Mr. James A. Mish | Corp. Pres, CEO, Member of Scientific Advisory Board & Director |
Mr. John E. Franzino | Chief Admin. Officer |
Mr. R. Hugh Kinsman | Chief Financial Officer |
Mr. John J. Miller | COO, Exec. Officer & Pres of Tobacco |
Dr. Calvin Treat | Chief Scientific Officer |
Ms. Mei Kuo | Director of Communications & Investor Relations |
Mr. Peter F. Ferola | Gen. Counsel & Sec. |
Mr. Henry Sicignano III, M.B.A., MBA | Consultant |
Mr. Steven P. Przybyla | Head of Hemp/Cannabis Bus. Devel. |
Mr. James C. Morrison | Technical Advisor & Regulatory Affairs Consultant |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Consumer Staples |
---|---|
GIC Group: | Food, Beverage & Tobacco |
GIC Industry: | Tobacco |
GIC Sub-Industry: | Tobacco |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 1.7679 |
Price-to-Sales TTM: | 4.3277 |
IPO Date: | 2011-01-26 |
Fiscal Year End: | December |
Full Time Employees: | 76 |